Ureter Endometriosis

In: Women's Health · 2016 · vol. 2(3) · doi:10.15406/mojwh.2016.02.00033 · W4245156678
article OA: bronze CC0
AI-generated summary by claude@2026-06, 2026-06-13

Ureter endometriosis, a rare cause of silent kidney loss, should be suspected during rectovaginal endometriosis treatment and can be surgically managed via laparoscopy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

AI-generated deep summary by claude@2026-06, 2026-06-13 · read from full text

This mini-review discusses ureter endometriosis, describing its rarity but noting that up to 12% of women with endometriosis may have urinary tract involvement and that ureteral disease can be “silent,” sometimes presenting with pelvic pain or delayed diagnosis that risks loss of kidney function. It outlines the anatomical distribution of urinary tract involvement and describes intrinsic versus extrinsic ureteral endometriosis, emphasizing extrinsic involvement as most common. The paper concludes that laparoscopic management is feasible, with a surgical strategy involving retroperitoneal inspection and ureter dissection beginning at the pelvic brim, followed by ureterolysis and resection/reimplantation only if stenosis, vascular compromise, or residual tissue is found; it also states specific postoperative ureter stent timing and need for CT urogram. This paper is centrally about endometriosis — specifically ureter endometriosis and its laparoscopic surgical management and diagnostic considerations in deep rectovaginal endometriosis.

Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works

Abstract

Ureter endometriosis is a rare clinical condition that can present itself as a silent kidney loss. This condition should be suspected in rectovaginal endometriosis treatment. This treatment is feasible by laparoscopy with ureterolysis, end-to-end anastomosis or reimplantation.
Full text 5,406 characters · extracted from oa-pdf · 6 sections · click to expand

Introduction

Ureter endometriosis is a rare clinical condition with up to 12% of women with endometriosis affected in the urinary tract. 1,2 The proportion of involvement of bladder, ureter and kidney is said to be 40:5:1. 3,4 Of special concern ureteral endometriosis is a silent disease with most patients without specific symptoms (related to the ureter) and, more commonly with pelvic pain (dysmenorrhea and dyspareunia) that affects most patients with endometriosis. In patients without pain symptoms the diagnosis of endometriosis can be delayed leading to silent loss of kidney function. 5,6 Ureteral endometriosis can be intrinsic or extrinsic to the ureteral wall. 7,8 Extrinsic type is considered the most common.9 Surgical treatment is feasible and safe. 10,11 Ureter endometriosis can be treated either by ureterolysis, segmental ureterectomy with end- to-end anastomosis or ureteroneocystostomy. The surgical strategy published by Wattiez et al.,12 starts with retroperitoneal inspection of ureters. Dissection of the ureter may need to begin at the pelvic brim and always strats in sano. We use bipolar forceps and scissors or the blunt tip of an aspirator to the dissection aiming to free the ureter from the endometriosis tissue. After ureterolysis the ureter is evaluated to check for wall stenosis, vascular compromise or with residual tissue. If one of this happens then resection with end-to-end reanastomosis or ureteroneocystectomy may be needed. In either case we use the double J stent keeping it in place until 6-8weeks after ureter resection doing a CT urogram at this time. If only ureterolysis the JJ stent is kept until 2weeks after surgery.

Conclusion

Even if ureteral endometriosis is considered a rare disease it should be always suspected in deep endometriosis patients as part of the surgical strategy. The main advantage is to isolate the rectovaginal nodule from the ureter keeping it safe during the surgery but also to rule out endometriosis involvement of the ureter that is most often without specific symptoms. Laparoscopic management of ureter endometriosis is feasible and surgeons should consider ureterolyis and if after that the ureter is compromised the either ureter partial resection with end-to-end anastomosis or ureteroneocystostomy.

Acknowledgements

None. Conflict of interest The author declares no conflict of interest.

References

1. Gustilo-Ashby AM, Paraiso MF. Treatment of urinary tract endometrio- sis. J Minim Invasive Gynecol. 2006;13(6):559–565. 2. Nezhat C, Nezhat F, Nezhat CH, et al. Urinary tract endometriosis treat- ed by laparoscopy. Fertil Steril. 1996;66(6):920–924. 3. Chapron C, Fauconnier A, Vieira M, et al. Anatomical distribution of deeply infiltrating endometriosis: surgical implications and proposition for a classification. Hum Reprod. 2003;18(1):157–161. 4. Collinet P, Marcelli F, Villers A, et al. Management of endometriosis of the urinary tract. Gynecol Obstet Fertil. 2006;34(4):347–352. 5. Seracchioli R, Mabrouk M, Manuzzi L, et al. Importance of retroperi - toneal ureteric evaluation in cases of deep infiltrating endometriosis. J Minim Invasive Gynecol. 2008;15(4):435–439. 6. Sanyal D, Argent VP. Silent pelvic endometriosis presenting as pyelone- phritis and ureteric obstruction. J Obstet Gynaecol. 2003;23(3):328–329. 7. Frenna V , Santos L, Ohana E, et al. Laparoscopic management of ureteral endometriosis: our experience. J Minim Invasive Gynecol . 2007;14(2):169–1671. 8. Stillwell TJ, Kramer SA, Lee RA. Endometriosis of ureter. Urology. 1986;28(2):81–85. 9. Chapron C, Chiodo I, Leconte M, et al. Severe ureteral endometriosis: the intrinsic type is not so rare after complete surgical exeresis of deep endometriotic lesions. Fertil Steril. 2010;93(7):2115–2120. 10. Lusuardi L, Hager M, Sieberer M, et al. Laparoscopic treatment of in - trinsic endometriosis of the urinary tract and proposal of a treatment scheme for ureteral endometriosis. Urology. 2012;80(5):1033–1038. 11. Gabriel B, Nassif J, Trompoukis P, et al. Prevalence and manage - ment of urinary tract endometriosis: a clinical case series. Urology. 2011;78(6):1269–1274. 12. Wattiez A, Puga M, Albornoz J, et al. Surgical strategy in endometriosis. Best Pract Res Clin Obstet Gynaecol. 2013;27(3):381–392. 80 © 2016 Alves. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and build upon your work non-commercially. Ureter endometriosis Volume 2 Issue 3 - 2016 Joao Sequeira Alves Hospital Garcia de Orta, Serviço Obstetrícia, Almada, Europe Correspondence: Joao Sequeira Alves, Hospital Garcia de Orta, Serviço Obstetrícia, Almada, Portugal, Europe, T el +351966125130, Email [email protected] Received: July 26, 2016 | Published: August 08, 2016

Abstract

Ureter endometriosis is a rare clinical condition that can present itself as a silent kidney loss. This condition should be suspected in rectovaginal endometriosis treatment. This treatment is feasible by laparoscopy with ureterolysis, end-to-end anastomosis or re- implantation.

Keywords

endometriosis, ureter, laparoscopy MOJ W omen’s Health Mini Review Open Access Citation: Alves JS. Ureter endometriosis. MOJ Womens Health. 2016;2(3):80. DOI: 10.15406/mojwh.2016.02.00033

Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.

My notes (saved in your browser only)

Ask this paper AI returns verbatim quotes from the full text · source: oa-pdf

Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works

Condition tags

endometriosisbowel_endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (12)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK